Menu
Back to Journals » Clinical and Experimental Gastroenterology » Volume 9
Clinical and Experimental Gastroenterology
ISSN: 1178-7023
- View all (545)
- Volume 17, 2024 (12)
- Volume 16, 2023 (26)
- Volume 15, 2022 (20)
- Volume 14, 2021 (51)
- Volume 13, 2020 (59)
- Volume 12, 2019 (44)
- Volume 11, 2018 (47)
- Volume 10, 2017 (34)
- Volume 9, 2016 (38)
- Volume 8, 2015 (34)
- Volume 7, 2014 (46)
- Volume 6, 2013 (28)
- Volume 5, 2012 (23)
- Volume 4, 2011 (32)
- Volume 3, 2010 (26)
- Volume 2, 2009 (20)
- Volume 1, 2008 (5)
Archive: Volume 9, 2016
Absorption and safety of serum-derived bovine immunoglobulin/protein isolate in healthy adults
Shaw AL, Mathews DW, Hinkle JE, Petschow BW, Weaver EM, Detzel CJ, Klein GL, Bradshaw TP
Clinical and Experimental Gastroenterology 2016, 9:365-375
Published Date: 5 December 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection
Sarrazin C, Castelli F, Andreone P, Buti M, Colombo M, Pol S, Calinas F, Puoti M, Olveira A, Shiffman M, Stern JO, Kukolj G, Roehrle M, Aslanyan S, Deng Q, Vinisko R, Mensa FJ, Nelson DR
Clinical and Experimental Gastroenterology 2016, 9:351-363
Published Date: 24 November 2016
Necrotizing pancreatitis: challenges and solutions
Bendersky VA, Mallipeddi MK, Perez A, Pappas TN
Clinical and Experimental Gastroenterology 2016, 9:345-350
Published Date: 31 October 2016
Comparison of Glasgow-Blatchford score and full Rockall score systems to predict clinical outcomes in patients with upper gastrointestinal bleeding
Mokhtare M, Bozorgi V, Agah S, Nikkhah M, Faghihi AH, Boghratian AH, Shalbaf N, Khanlari A, Seifmanesh H
Clinical and Experimental Gastroenterology 2016, 9:337-343
Published Date: 31 October 2016
Managing inflammatory bowel disease in pregnancy: current perspectives
Pinder M, Lummis K, Selinger CP
Clinical and Experimental Gastroenterology 2016, 9:325-335
Published Date: 14 October 2016
Systematic review: treatment pattern and clinical effectiveness and safety of pharmaceutical therapies for Crohn’s disease in Europe
Lelli F, Nuhoho S, Lee XY, Xu WW
Clinical and Experimental Gastroenterology 2016, 9:311-323
Published Date: 5 October 2016
Cigarette smoking adversely affects disease activity and disease-specific quality of life in patients with Crohn’s disease at a tertiary referral center
Quezada SM, Langenberg P, Cross RK
Clinical and Experimental Gastroenterology 2016, 9:307-310
Published Date: 22 September 2016
Splenosis involving the gastric fundus, a rare cause of massive upper gastrointestinal bleeding: a case report and review of the literature
Reinglas J, Perdrizet K, Ryan SE, Patel RV
Clinical and Experimental Gastroenterology 2016, 9:301-305
Published Date: 22 September 2016
Ineffective esophageal motility and the vagus: current challenges and future prospects
Chen JH
Clinical and Experimental Gastroenterology 2016, 9:291-299
Published Date: 20 September 2016
Managing eosinophilic esophagitis: challenges and solutions
Shah NA, Albert DM, Hall NM, Moawad FJ
Clinical and Experimental Gastroenterology 2016, 9:281-290
Published Date: 16 September 2016
Influence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune system
Stier H, Bischoff SC
Clinical and Experimental Gastroenterology 2016, 9:269-279
Published Date: 13 September 2016
Self-management in patients with inflammatory bowel disease: strategies, outcomes, and integration into clinical care
Plevinsky JM, Greenley RN, Fishman LN
Clinical and Experimental Gastroenterology 2016, 9:259-267
Published Date: 23 August 2016
Acute left-sided colonic diverticulitis: clinical expressions, therapeutic insights, and role of computed tomography
Ambrosetti P
Clinical and Experimental Gastroenterology 2016, 9:249-257
Published Date: 18 August 2016
Optimal delivery of follow-up care after surgery for Crohn’s disease: current perspectives
Campbell JP, Vaughn BP
Clinical and Experimental Gastroenterology 2016, 9:237-248
Published Date: 8 August 2016
Improving outcomes of refractory celiac disease – current and emerging treatment strategies
Woodward J
Clinical and Experimental Gastroenterology 2016, 9:225-236
Published Date: 3 August 2016
An update on antibody-based immunotherapies for Clostridium difficile infection
Hussack G, Tanha J
Clinical and Experimental Gastroenterology 2016, 9:209-224
Published Date: 1 August 2016
Hereditary pancreatitis: current perspectives
Raphael KL, Willingham FF
Clinical and Experimental Gastroenterology 2016, 9:197-207
Published Date: 26 July 2016
Translational and clinical perspectives on sphincter of Oddi dysfunction
Kyanam Kabir Baig KR, Wilcox CM
Clinical and Experimental Gastroenterology 2016, 9:191-195
Published Date: 28 July 2016
How do patients’ clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure?
Bächler T, le Roux CW, Bueter M
Clinical and Experimental Gastroenterology 2016, 9:181-189
Published Date: 22 July 2016
Safety of polyethylene glycol 3350 solution in chronic constipation: randomized, placebo-controlled trial
McGraw T
Clinical and Experimental Gastroenterology 2016, 9:173-180
Published Date: 15 July 2016
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
Mermelstein J, Mermelstein AC, Chait MM
Clinical and Experimental Gastroenterology 2016, 9:163-172
Published Date: 13 July 2016
Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
Ford DC, Dahl NV, Strauss WE, Barish CF, Hetzel DJ, Bernard K, Li Z, Allen LF
Clinical and Experimental Gastroenterology 2016, 9:151-162
Published Date: 11 July 2016
Gastroesophageal reflux disease symptoms in the Greek general population: prevalence and risk factors
Spantideas N, Drosou E, Bougea A, Assimakopoulos D
Clinical and Experimental Gastroenterology 2016, 9:143-149
Published Date: 21 June 2016
Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
Nanayakkara WS, Skidmore PML, O’Brien L, Wilkinson TJ, Gearry RB
Clinical and Experimental Gastroenterology 2016, 9:131-142
Published Date: 17 June 2016
Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach
Christophi GP, Rengarajan A, Ciorba MA
Clinical and Experimental Gastroenterology 2016, 9:125-130
Published Date: 19 May 2016
Recent developments in choledochoscopy: technical and clinical advances
Xu MM, Kahaleh M
Clinical and Experimental Gastroenterology 2016, 9:119-124
Published Date: 11 May 2016
Essential phospholipids in fatty liver: a scientific update
Gundermann KJ, Gundermann S, Drozdzik M, Mohan Prasad VG
Clinical and Experimental Gastroenterology 2016, 9:105-117
Published Date: 5 May 2016
Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
von Arnim U, Wex T, Ganzert C, Schulz C, Malfertheiner P
Clinical and Experimental Gastroenterology 2016, 9:97-103
Published Date: 21 April 2016
Automated image analysis in the study of collagenous colitis
Fiehn AM, Kristensson M, Engel U, Munck LK, Holck S, Engel PJH
Clinical and Experimental Gastroenterology 2016, 9:89-95
Published Date: 8 April 2016
Profile of acotiamide in the treatment of functional dyspepsia
Ueda M, Iwasaki E, Suzuki H
Clinical and Experimental Gastroenterology 2016, 9:83-88
Published Date: 6 April 2016
Clinical management of achalasia: current state of the art
Krill JT, Naik RD, Vaezi MF
Clinical and Experimental Gastroenterology 2016, 9:71-82
Published Date: 4 April 2016
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets
Manuc TE, Manuc MM, Diculescu MM
Clinical and Experimental Gastroenterology 2016, 9:59-70
Published Date: 15 March 2016
A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease
Taft TH, Keefer L
Clinical and Experimental Gastroenterology 2016, 9:49-58
Published Date: 7 March 2016
Identifying factors associated with clinical success in patients treated with NASHA®/Dx injection for fecal incontinence
Franklin H, Barrett AC, Wolf R
Clinical and Experimental Gastroenterology 2016, 9:41-47
Published Date: 2 March 2016
Optimal management of collagenous colitis: a review
O’Toole A
Clinical and Experimental Gastroenterology 2016, 9:31-39
Published Date: 10 February 2016
Fecal calprotectin in inflammatory bowel disease
Walsham NE, Sherwood RA
Clinical and Experimental Gastroenterology 2016, 9:21-29
Published Date: 28 January 2016
Electrical stimulation for gastroesophageal reflux disease: current state of the art
Kim SE, Soffer E
Clinical and Experimental Gastroenterology 2016, 9:11-19
Published Date: 14 January 2016
Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center
Michopoulos S, Chouzouri VI, Manios ED, Grapsa E, Antoniou Z, Papadimitriou CA, Zakopoulos N, Dimopoulos AM
Clinical and Experimental Gastroenterology 2016, 9:1-9
Published Date: 13 January 2016